# Rubicon Research Ltd (RUBICON)
> Exchange: NSE | Sector: Pharma | ISIN: INE506V01022

## Price
Current Price: ₹1,801.8
Day Change: -0.42%
52W High: ₹1899
52W Low: ₹570.75
Market Cap: ₹29,745 Cr

## About
Rubicon Research Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 167.04%

## Valuation
P/E: 103.8
P/B: 23.1
EPS: ₹17.36
Book Value: ₹78.07
Dividend Yield: 0.08%

## Profitability
ROE: 27.0%

## Access
Current tier: anonymous
More history: Register free to see 5 more years.

## Data Freshness
Quote Updated: 2026-09-10T05:16:00.000Z
Price History Updated: 2026-09-10T18:56:33.777Z
Latest Price History Date: 2026-09-10
Technicals Updated: 2026-09-10T18:56:33.777Z
Quant Updated: 2026-09-10T18:56:33.777Z
Sentiment Updated: 2026-09-10T18:56:33.777Z
Financials Status: current
Financials Updated: 2026-09-02T13:26:46.524Z
Financials Last Attempt: 2026-09-11T22:35:53.468Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹1936 Cr
Operating Profit: ₹450 Cr (OPM 23%)
Net Profit: ₹288 Cr
Tax: ₹83 Cr

## Annual P&L History
TTM: Rev ₹1936Cr | PAT ₹288Cr | OPM 23%
FY26: Rev ₹1754Cr | PAT ₹247Cr | OPM 23%
FY25: Rev ₹1284Cr | PAT ₹134Cr | OPM 21%

## Balance Sheet (FY26)
Total Assets: ₹2327 Cr
Total Liabilities: ₹2327 Cr
Borrowings: ₹311 Cr
Cash: —

## Shareholding
Promoters: 59.76%
FIIs: 7.52%
DIIs: 9.43%
Public: 23.29%

---
Source: rupiya.io/stocks/rubicon
Disclaimer: For research and education only. Not investment advice.